National Standard Line

MAJOR CANCERS

Specialized Package for Major Cancer Screening — Multi-organ cancer detection with comprehensive tumor markers and genetic testing.

MAJOR CANCERS

Specialized Package for Major Cancer Screening — Multi-organ cancer detection with comprehensive tumor markers and genetic testing.

2–3h

Duration

$810~

Price

What's Included

Full Basic Examination (baseline tests, functional tests, urinalysis, blood tests, X-ray, gynecologic exam)
Tumor Markers: AFP, CEA, PSA, CA125, CA19-9, CYFRA
Ultrasound: Abdomen, Thyroid, Prostate (Male), Breast (Female), Uterus (Female)
Genetic Test: 5 Common Cancers
Select 1 Gastric Test: Gastroscopy / Upper GI Series / Pepsinogen
Select 1 Colon Test: Colonoscopy / M2-PK / EarlyTect

What Is the MAJOR CANCERS Package?

The MAJOR CANCERS Package is designed for multi-organ cancer detection — combining 6 tumor markers, full-body ultrasound, gastric and colon testing, and a genetic cancer panel. This is the most comprehensive cancer screening available in a single visit.

Covering liver, colorectal, stomach, prostate, ovarian, and lung cancers with genetic risk profiling for 5 common cancer types.

6 tumor markers: AFP, CEA, PSA, CA125, CA19-9, CYFRA
Multi-organ ultrasound (5 organs)
Gastric + colon test selection
Genetic test for 5 common cancers

What's Included

Low-Dose Lung CT (LDCT)

The most sensitive screening for early-stage lung cancer, recommended for current or former smokers.

8-Marker Tumor Panel

AFP, CEA, CA 19-9, CA 125, PSA, CA 15-3, CYFRA 21-1, and SCC — targeting liver, colorectal, pancreatic, ovarian, prostate, and lung cancers.

Multi-Organ Ultrasound

Liver, gallbladder, pancreas, kidneys, thyroid, prostate/uterus — full abdominal and organ ultrasound.

Gastroscopy + Colonoscopy

Direct endoscopic examination of the stomach and colon for early cancer detection.

Genetic Cancer Panel (Optional)

Hereditary cancer risk assessment including BRCA1/2, APC, and MSH markers.

Chest X-Ray + Mammography

Digital chest imaging and breast cancer screening (women).

Low-Dose CT: Lung Cancer Detection

Low-Dose CT (LDCT) is the only imaging method proven to reduce lung cancer mortality, detecting tumors as small as 3mm — often years before symptoms appear.

Unlike standard chest X-rays, LDCT provides three-dimensional cross-sectional images of the entire lung, able to identify nodules, infiltrates, and structural abnormalities with exceptional detail.

The scan takes less than 10 minutes and uses 90% less radiation than a standard CT, making it safe for annual screening.

Multi-Cancer Tumor Marker Panel

KMI's 8-marker tumor panel simultaneously screens for multiple cancer types using a single blood draw. Each marker corresponds to a specific cancer: AFP for liver, CEA for colorectal, CA 19-9 for pancreatic, CA 125 for ovarian, and PSA for prostate.

While tumor markers are not a standalone diagnosis, elevated levels trigger targeted imaging follow-up — creating a two-layer screening safety net.

This combined approach (markers + imaging + endoscopy) gives the highest multi-cancer detection rate achievable in a single outpatient visit.